Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model

被引:91
作者
Bertaina-Anglade, Valerie
la Rochelle, Christophe Drieu
Boyer, Pierre-Alain
Mocaer, Elisabeth
机构
[1] Biotrial, Dept Preclin Pharmacol, F-35000 Rennes, France
[2] Inst Rech Int Servier, F-92415 Courbevoie, France
来源
BEHAVIOURAL PHARMACOLOGY | 2006年 / 17卷 / 08期
关键词
agomelatine; antidepressant; imipramine; learned helplessness; melatonin; rat;
D O I
10.1097/FBP.0b013e3280116e5c
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
To confirm the antidepressant-like activity of agomelatine (S 20098), a melatonin agonist and 5-hydroxytryptamine(2c) antagonist, already reported in the chronic mild stress and forced swimming tests, the effects of agomelatine were investigated in the learned helplessness test and compared with those of imipramine, melatonin and a selective 5-hydroxytryptamine(2c) antagonist, SB-242084. Agomelatine was administered for 5 days either once a day or twice a day, and the effects of pretreatment by a melatonin receptor antagonist, S 22153 (20 mg/kg/day), were studied. A deficit in avoidance learning was observed in helpless control animals. Agomelatine (10 mg/kg/day) administered once a day significantly reduced this deficit with an effect similar to that of imipramine. Effects of agomelatine were abolished by S 22153 pretreatment. Melatonin or SB-242084 did not reduce the deficit of helpless control animals. These results confirm the antidepressant-like activity of agomelatine and suggest a role of melatonin receptors in its mechanism of action. Behavioural Pharmacology 17:703-713 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:703 / 713
页数:11
相关论文
共 57 条
  • [1] SUCCESSFUL USE OF S20098 AND MELATONIN IN AN ANIMAL-MODEL OF DELAYED SLEEP-PHASE SYNDROME (DSPS)
    ARMSTRONG, SM
    MCNULTY, OM
    GUARDIOLALEMAITRE, B
    REDMAN, JR
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (01) : 45 - 49
  • [2] BAKISH D, 1993, J CLIN PSYCHOPHARM, V13, P409
  • [3] BONNEFOND C, 1993, INT CONGR SER, V1017, P123
  • [4] Bourin M, 2004, J PSYCHIATR NEUROSCI, V29, P126
  • [5] CARMAN JS, 1976, AM J PSYCHIAT, V133, P1181
  • [6] Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats
    Chagraoui, A
    Protais, P
    Filloux, T
    Mocaër, E
    [J]. PSYCHOPHARMACOLOGY, 2003, 170 (01) : 17 - 22
  • [7] Characterisation of human melatonin mt1 and MT2 receptors by CRE-luciferase reporter assay
    Conway, S
    Canning, SJ
    Howell, HE
    Mowat, ES
    Barrett, P
    Drew, JE
    Delagrange, P
    Lesieur, D
    Morgan, PJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 390 (1-2) : 15 - 24
  • [8] Dalton EJ, 2000, J PSYCHIATR NEUROSCI, V25, P48
  • [9] Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression
    deVries, MW
    Peeters, FPML
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1997, 185 (03) : 201 - 202
  • [10] Melatonin for the treatment of sleep disturbances in major depressive disorder
    Dolberg, OT
    Hirschmann, S
    Grunhaus, L
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (08) : 1119 - 1121